Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Eugenia, Pareja"'
Autor:
Guillem Garcia-Llorens, Teresa Martínez-Sena, Eugenia Pareja, Laia Tolosa, José V. Castell, Roque Bort
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-19 (2023)
Abstract Background High-throughput pharmaco-toxicological testing frequently relies on the use of established liver-derived cell lines, such as HepG2 cells. However, these cells often display limited hepatic phenotype and features of neoplastic tran
Externí odkaz:
https://doaj.org/article/62a962e9da144657bf30508219281295
Autor:
Álvaro Pérez-Rubio, Polina Soluyanova, Erika Moro, Guillermo Quintás, Iván Rienda, María Dolores Periañez, Andrés Painel, José Vizuete, Judith Pérez-Rojas, José V. Castell, Ramón Trullenque-Juan, Eugenia Pareja, Ramiro Jover
Publikováno v:
Nutrients, Vol 15, Iss 14, p 3187 (2023)
Bariatric surgery (BS) has several benefits, including resolution of non-alcoholic fatty liver disease (NAFLD) in many patients. However, a significant percentage of patients do not experience improvement in fatty liver after BS, and more than 10% de
Externí odkaz:
https://doaj.org/article/a170d0eaefee49e2953c33f3d1091aed
Autor:
Guillermo Quintás, Florian Caiment, Iván Rienda, Judith Pérez-Rojas, Eugenia Pareja, José V. Castell, Ramiro Jover
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 9298 (2022)
Non-alcoholic fatty liver disease (NAFLD) is the most prevalent form of chronic liver disease worldwide, but a reliable non-invasive method to quantify liver steatosis in primary healthcare is not available. Circulating microRNAs have been proposed a
Externí odkaz:
https://doaj.org/article/697605491f3b42cba242a82d0d4e23e6
Autor:
Iván Rienda, Isabel Ten-Doménech, Erika Moro, Marta Moreno-Torres, Judith Pérez-Rojas, Eugenia Pareja, Alvaro Perez-Rubio, Ramon Trullenque-Juan, Ramiro Jover, Bernhard Lendl, David Perez-Guaita, Julia Kuligowski, José V Castell, Guillermo Quintás
Publikováno v:
The Analyst.
The assessment of liver steatosis is crucial in both hepatology and liver transplantation (LT) surgery. Steatosis can negatively impact the success of the LT. Steatosis is a factor for excluding...
Autor:
Guillermo Quintás, Jos Kleinjans, Eugenia Pareja Ibars, Teresa Martínez-Sena, Isabel Conde, José V Castell
Publikováno v:
Archives of Toxicology
ARCHIVES OF TOXICOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FISABIO. Repositorio Institucional de Producción Científica
ARCHIVES OF TOXICOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FISABIO. Repositorio Institucional de Producción Científica
Drug-induced liver injury (DILI) is an adverse toxic hepatic clinical reaction associated to the administration of a drug that can occur both at early clinical stages of drug development, as well after normal clinical usage of approved drugs. Because
Autor:
Victoria Aguilera, M.D., Isabel Ferrer, Marina Berenguer, Jairo Rivera, Ángel Rubín, Ángel Moya, Eugenia Pareja, Jaime Sánchez, Martín Prieto, José Mir
Publikováno v:
Annals of Hepatology, Vol 12, Iss 2, Pp 274-281 (2013)
Introduction. Combined liver-kidney transplantation (LKT) is the best therapeutic option for patients with end-stage liver and kidney disease. Objectives. To analyze baseline characteristics and clinical outcome of LKT compared to isolated liver tran
Externí odkaz:
https://doaj.org/article/0f5ee7ab3a6144859d5ddc06bfb2bd5c
Autor:
Laia Tolosa, Eugenia Pareja-Ibars, M. Teresa Donato, Miriam Cortés, Silvia López, Nuria Jiménez, José Mir, José V. Castell, M. José Gómez-Lechón
Publikováno v:
Cell Transplantation, Vol 23 (2014)
Hepatocyte transplantation is an alternative therapy to orthotopic liver transplantation for the treatment of liver diseases. However, the supply of hepatocytes is limited given the shortage of organs available to isolate good-functioning quality cel
Externí odkaz:
https://doaj.org/article/85b65dc5095a449a929dbfd0c6d0f72d
Autor:
Carlos Domingo del Pozo, Paula Gonzálvez-guardiola, Sandra Santarrufina-Martínez, Carmen Payá-Llorente, Eugenia Pareja-Ibars, Aleix Martínez-Pérez
Publikováno v:
HPB
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Background: Laparoscopic common bile duct exploration (LCBDE) is an effective treatment for choledocholithiasis. The aim of this study was to determine the predictive factors associated with conversion during LCBDE and to assess the implications of c
Autor:
Carmen Ribes-Koninckx, Eugenia Pareja Ibars, Maria Ángeles Calzado Agrasot, Ana Bonora-Centelles, Begoña Polo Miquel, Juan José Vila Carbó, Ester Donat Aliaga, Jose Mir Pallardó, Maria José Gómez-Lechón, Jose V. Castell
Publikováno v:
Cell Transplantation, Vol 21 (2012)
Hepatocyte transplantation (HT) has become an effective therapy for patients with metabolic inborn errors. We report the clinical outcome of four children with metabolic inborn errors that underwent HT, describing the cell infusion protocol and the m
Externí odkaz:
https://doaj.org/article/b4adb4e2fda44f99a5d1455f973aca3d
Publikováno v:
Annals of Translational Medicine
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Annals of translational medicine
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Ann Transl Med
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Annals of translational medicine
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Ann Transl Med
The only curative treatment for severe end-stage liver disease (ESLD) is liver transplantation (LT) but it is limited by the shortage of organ donors. The increase of the incidence of liver disease has led to develop new therapeutic approaches such a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49788efd0cadc5a40d9cc350ace0053d
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7829
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=7829